Elixxer Total Debt vs. Revenue
ELXR Stock | CAD 1.15 0.00 0.00% |
For Elixxer profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Elixxer to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Elixxer utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Elixxer's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Elixxer over time as well as its relative position and ranking within its peers.
Elixxer |
Elixxer Revenue vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Elixxer's current stock value. Our valuation model uses many indicators to compare Elixxer value to that of its competitors to determine the firm's financial worth. Elixxer is rated as one of the top companies in total debt category among its peers. It also is rated as one of the top companies in revenue category among its peers totaling about 0.02 of Revenue per Total Debt. The ratio of Total Debt to Revenue for Elixxer is roughly 53.69 . At this time, Elixxer's Total Revenue is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Elixxer's earnings, one of the primary drivers of an investment's value.Elixxer Total Debt vs. Competition
Elixxer is rated as one of the top companies in total debt category among its peers. Total debt of Health Care industry is currently estimated at about 2.8 Billion. Elixxer adds roughly 4.41 Million in total debt claiming only tiny portion of equities under Health Care industry.
Elixxer Revenue vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Elixxer |
| = | 4.41 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Elixxer |
| = | 82.13 K |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Elixxer Revenue vs Competition
Elixxer is rated as one of the top companies in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 1.45 Billion. Elixxer adds roughly 82,126 in revenue claiming only tiny portion of equities under Health Care industry.
Elixxer Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Elixxer, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Elixxer will eventually generate negative long term returns. The profitability progress is the general direction of Elixxer's change in net profit over the period of time. It can combine multiple indicators of Elixxer, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last Reported | Projected for Next Year | ||
Net Interest Income | -2.5 M | -2.7 M | |
Interest Income | 9.4 K | 8.9 K | |
Operating Income | -2.5 M | -2.7 M | |
Net Loss | -6.1 M | -6.4 M | |
Income Before Tax | -6.1 M | -6.4 M | |
Total Other Income Expense Net | -1 M | -1.1 M | |
Net Loss | -6.2 M | -6.5 M | |
Net Loss | -16.3 M | -17.1 M | |
Change To Netincome | 429.7 K | 408.2 K |
Elixxer Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Elixxer. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Elixxer position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Elixxer's important profitability drivers and their relationship over time.
Use Elixxer in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Elixxer position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elixxer will appreciate offsetting losses from the drop in the long position's value.Elixxer Pair Trading
Elixxer Pair Trading Analysis
The ability to find closely correlated positions to Elixxer could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Elixxer when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Elixxer - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Elixxer to buy it.
The correlation of Elixxer is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Elixxer moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Elixxer moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Elixxer can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Elixxer position
In addition to having Elixxer in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Non-Metallic and Industrial Metal Mining Thematic Idea Now
Non-Metallic and Industrial Metal Mining
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Non-Metallic and Industrial Metal Mining theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Non-Metallic and Industrial Metal Mining Theme or any other thematic opportunities.
View All Next | Launch |
Additional Tools for Elixxer Stock Analysis
When running Elixxer's price analysis, check to measure Elixxer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elixxer is operating at the current time. Most of Elixxer's value examination focuses on studying past and present price action to predict the probability of Elixxer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elixxer's price. Additionally, you may evaluate how the addition of Elixxer to your portfolios can decrease your overall portfolio volatility.